Literature DB >> 19633156

Experimental models of tuberculosis: can we trust the mouse?

Denis Anthony Mitchison, Kwok Chiu Chang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19633156     DOI： 10.1164/rccm.200905-0708ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  13 in total

Review 1.  The chemical biology of new drugs in the development for tuberculosis.

Authors:  Clifton E Barry; John S Blanchard
Journal:  Curr Opin Chem Biol       Date:  2010-05-07       Impact factor: 8.822

2.  Mycobacterial Protein Tyrosine Phosphatases A and B Inhibitors Augment the Bactericidal Activity of the Standard Anti-tuberculosis Regimen.

Authors:  Noton K Dutta; Rongjun He; Michael L Pinn; Yantao He; Francis Burrows; Zhong-Yin Zhang; Petros C Karakousis
Journal:  ACS Infect Dis       Date:  2015-12-24       Impact factor: 5.084

Review 3.  The chemotherapy of tuberculosis: past, present and future.

Authors:  D Mitchison; G Davies
Journal:  Int J Tuberc Lung Dis       Date:  2012-06       Impact factor: 2.373

4.  Bactericidal potencies of new regimens are not predictive of their sterilizing potencies in a murine model of tuberculosis.

Authors:  Koen Andries; Tom Gevers; Nacer Lounis
Journal:  Antimicrob Agents Chemother       Date:  2010-08-16       Impact factor: 5.191

5.  Evaluation of moxifloxacin-containing regimens in pathologically distinct murine tuberculosis models.

Authors:  Si-Yang Li; Scott M Irwin; Paul J Converse; Khisi E Mdluli; Anne J Lenaerts; Eric L Nuermberger
Journal:  Antimicrob Agents Chemother       Date:  2015-04-27       Impact factor: 5.191

6.  An in vivo platform for rapid high-throughput antitubercular drug discovery.

Authors:  Kevin Takaki; Christine L Cosma; Mark A Troll; Lalita Ramakrishnan
Journal:  Cell Rep       Date:  2012-07-20       Impact factor: 9.423

7.  Differential virulence and disease progression following Mycobacterium tuberculosis complex infection of the common marmoset (Callithrix jacchus).

Authors:  Laura E Via; Danielle M Weiner; Daniel Schimel; Philana Ling Lin; Emmanuel Dayao; Sarah L Tankersley; Ying Cai; M Teresa Coleman; Jaime Tomko; Praveen Paripati; Marlene Orandle; Robin J Kastenmayer; Michael Tartakovsky; Alexander Rosenthal; Damien Portevin; Seok Yong Eum; Saher Lahouar; Sebastien Gagneux; Douglas B Young; Joanne L Flynn; Clifton E Barry
Journal:  Infect Immun       Date:  2013-05-28       Impact factor: 3.441

Review 8.  Modeling tuberculosis in nonhuman primates.

Authors:  Charles A Scanga; JoAnne L Flynn
Journal:  Cold Spring Harb Perspect Med       Date:  2014-09-11       Impact factor: 6.915

Review 9.  A medicinal chemists' guide to the unique difficulties of lead optimization for tuberculosis.

Authors:  Véronique Dartois; Clifton E Barry
Journal:  Bioorg Med Chem Lett       Date:  2013-07-12       Impact factor: 2.823

10.  Shortening Tuberculosis Treatment With Fluoroquinolones: Lost in Translation?

Authors:  Jean-Philippe Lanoix; Richard E Chaisson; Eric L Nuermberger
Journal:  Clin Infect Dis       Date:  2015-11-01       Impact factor: 9.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.